XML 175 R147.htm IDEA: XBRL DOCUMENT v3.25.1
Common Stock (Details)
3 Months Ended 12 Months Ended
May 13, 2025
$ / shares
shares
Apr. 15, 2025
shares
Mar. 31, 2025
Vote
$ / shares
shares
Dec. 31, 2024
Vote
$ / shares
shares
Dec. 31, 2023
$ / shares
shares
Dec. 17, 2024
$ / shares
Common Stock            
Common stock, shares authorized (in shares)     58,251,629 58,251,629 58,251,629  
Common stock, par value (in dollars per share) | $ / shares     $ 0.001 $ 0.001 $ 0.001 $ 0.001
Common stock, shares issued (in shares)     19,203,330 19,197,914 19,134,164  
Common stock, shares outstanding (in shares)     19,203,330 19,197,914 19,134,164  
Number of votes per share | Vote     1 1    
Dividend declared | $ / shares     $ 0 $ 0 $ 0  
Shares reserved for future issuance     36,009,537 36,014,953 36,078,703  
Cara Therapeutics Inc.            
Common Stock            
Common stock, par value (in dollars per share) | $ / shares           $ 0.001
Cara Therapeutics Inc. | Subsequent Event            
Common Stock            
Common stock, par value (in dollars per share) | $ / shares $ 0.001          
Number of converted shares upon closing of merger 6,539,404          
Common Stock | Cara Therapeutics Inc. | Subsequent Event            
Common Stock            
Number of converted shares upon closing of merger   2,575,494